Top Markets
#1 Palladium Network Palladium Network +27.91%
#2 Ankr Network Ankr Network +23.31%
#3 Pons Pons +13.49%
#4 Status Status +13.44%
#5 BankrCoin BankrCoin +11.35%
#6 ICON ICON +11.33%
#7 Wiki Cat Wiki Cat +8.34%
#8 Siren Siren +8.02%
#9 WAX WAX +7.72%
#10 RedStone RedStone +7.43%
Coin of the day
Palladium Network Palladium Network
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Regulus Therapeutics Inc. Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
Classement en actions #17602
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development... Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compound engineered to inhibit miR-21, which is currently in a Phase II clinical study for Alport syndrome, a severe renal condition. Another significant candidate, RGLS8429, an anti-miR agent targeting miR-17, is being evaluated in a Phase 1b clinical trial for autosomal dominant polycystic kidney disease. Beyond these clinical programs, Regulus is also cultivating an extensive preclinical portfolio, emphasizing drug candidates with precise, organ-selective delivery strategies. The company was established in 2007.
Prix de l'action
$8.16
Dernière synchronisation: 2025-06-26
Capitalisation boursière
$234.57M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Regulus Therapeutics Inc. (RGLS)

Catégorie

Healthcare
EPS pour Regulus Therapeutics Inc. (RGLS)
EPS au March 2025 TTM : $-0.73
Selon les derniers rapports financiers et le cours de l'action de Regulus Therapeutics Inc., l’EPS actuel de la société (TTM) est de $-0.73. À la fin de 2023, la société avait un EPS de $-1.58 une diminution par rapport à celui de 2022, qui était de $-1.86.
Historique de l'EPS de Regulus Therapeutics Inc. de 2010 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-0.73 -10.98%
2024 $-0.82 -48.10%
2023 $-1.58 -15.05%
2022 $-1.86 -42.59%
2021 $-3.24 -28.00%
2020 $-4.50 -58.22%
2019 $-10.77 -80.72%
2018 $-55.87 -32.67%
2017 $-82.98 -55.37%
2016 $-185.94 42.90%
2015 $-130.12 -15.65%
2014 $-154.27 164.98%
2013 $-58.22 -77.11%
2012 $-254.37 -92.84%
2011 $-3.55K -51.14%
2010 $-7.27K 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -2,472.60%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -3,900.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 993.15%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 624.66%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH